公开(公告)号：US4935241A

公开(公告)日：1990-06-19

申请号：US266894

申请日：1988-11-03

申请人： Izumi Saitoh ,  Kaori Ikeda ,  Shigeru Kido ,  Yoshio Doi ,  Shohei Egawa

发明人： Izumi Saitoh ,  Kaori Ikeda ,  Shigeru Kido ,  Yoshio Doi ,  Shohei Egawa

IPC分类号： A61K9/70 ,  A61K31/415 ,  A61K47/10 ,  A61K47/32 ,  A61K47/38 ,  A61P17/00

CPC分类号： A61K31/415 ,  A61K47/32 ,  A61K47/38 ,  A61K9/0014 ,  Y10S514/858 ,  Y10S514/964

摘要： A pharmaceutical preparation for the treatment of tinea pedis, containing as basic components about 0.1% to about 2.5% of croconazole hydrochloride and about 1%-15% of an ethyl acrylate-methyl methacrylate copolymer in an aqueous alcohol, and if necessary, about 0.1% to about 2.5% of a thickening agent and/or a plasticizer.

公开(公告)号：US4915940A

公开(公告)日：1990-04-10

申请号：US271304

申请日：1988-11-15

申请人： Izumi Saitoh ,  Kaori Ikeda ,  Yoshio Doi ,  Shohei Egawa

发明人： Izumi Saitoh ,  Kaori Ikeda ,  Yoshio Doi ,  Shohei Egawa

IPC分类号： A61K9/70 ,  A61K31/27 ,  A61P31/04 ,  A61P31/10

CPC分类号： A61K31/27 ,  A61K9/7015

摘要： Film-formation-type antifungal preparations for external application, consisting essentially of about 0.1% to about 1.5% of tolnaphtate, about 10% to about 20% of a dimethylaminoethyl methacrylate-methacrylic acid ester copolymer and 0.5% to about 10% of a medium chain fatty acid ester in an alcoholic solvent but containing practically no water.

公开(公告)号：US5086077A

公开(公告)日：1992-02-04

申请号：US604921

申请日：1990-10-29

申请人： Sakae Obara ,  Hiroaki Muto ,  Sumiko Mizuno ,  Tohru Chiba ,  Izumi Saitoh ,  Kaori Ikeda

发明人： Sakae Obara ,  Hiroaki Muto ,  Sumiko Mizuno ,  Tohru Chiba ,  Izumi Saitoh ,  Kaori Ikeda

IPC分类号： A61K9/06 ,  A61K47/38 ,  C08B11/02

CPC分类号： A61K9/0014 ,  A61K47/38 ,  Y10S514/944 ,  Y10S514/946 ,  Y10S514/947

摘要： A novel endermic medicament having a consistency of a gel is proposed which is formulated, as a gel base, with non-ionic water-soluble cellulose ether, e.g., methyl cellulose and hydroxypropyl methyl cellulose, modified with a modification agent containing, in the molecule, an alkyl group having 6 to 26 carbon atoms and a functional group having reactivity with the hydroxyl group in the cellulose ether, e.g., stearyl glycidyl ether, decyl glycidyl ether and cetyl epoxide. The endermic medicament formulated with the modified cellulose ether is stable by virtue of the very little interaction between the active ingredients and the gel base and also can exhibit high percutaneous absorptivity of the active ingredients through the human skin.

公开(公告)号：US5508357A

公开(公告)日：1996-04-16

申请号：US307543

申请日：1994-09-16

申请人： Hidekazu Matsuura ,  Yoshihide Iwasaki ,  Kaori Ikeda ,  Takayuki Suzuki ,  Masashi Tanaka ,  Yasuo Miyadera

发明人： Hidekazu Matsuura ,  Yoshihide Iwasaki ,  Kaori Ikeda ,  Takayuki Suzuki ,  Masashi Tanaka ,  Yasuo Miyadera

IPC分类号： C08G73/10 ,  C08L79/08 ,  C09J179/08 ,  H05K3/38 ,  C08F283/04

CPC分类号： C08L79/085 ,  C08G73/1042 ,  C08J5/24 ,  C08L79/08 ,  C09J179/08 ,  C08J2379/08 ,  H05K3/386 ,  Y10S525/928 ,  Y10T428/2852 ,  Y10T428/31511 ,  Y10T428/31721

摘要： A polyimide comprises structural units represented by the following formula: ##STR1## wherein Ar is a group consisting of 10-90 mole % of a first specific structural sub-unit and 90-10 mole % of a second particular structural sub-unit. A process for the production of the polyimide and a thermosetting resin composition comprising the polyimide and a particular polymaleimide are also disclosed.

摘要翻译： 聚酰亚胺包含由下式表示的结构单元：其中Ar是由10-90摩尔％的第一特定结构子单元和90-10摩尔％的第二特定结构子单元组成的组。 还公开了制备聚酰亚胺的方法和包含聚酰亚胺和特定聚马来酰亚胺的热固性树脂组合物。

公开(公告)号：US20080044606A1

公开(公告)日：2008-02-21

申请号：US11663886

申请日：2005-09-26

申请人： Kenji Omori ,  Takeshi Nizuka ,  Dai Sudo ,  Manabu Fujimoto ,  Koichi Miura ,  Toyoaki Suzuki ,  Kaori Ikeda ,  Hideji Kashiwagi ,  Hidetoshi Myojyo ,  Masashi Moteki

发明人： Kenji Omori ,  Takeshi Nizuka ,  Dai Sudo ,  Manabu Fujimoto ,  Koichi Miura ,  Toyoaki Suzuki ,  Kaori Ikeda ,  Hideji Kashiwagi ,  Hidetoshi Myojyo ,  Masashi Moteki

IPC分类号： A61J1/00 ,  B32B27/32

CPC分类号： A61J1/2093 ,  A61J1/10 ,  A61J1/2024 ,  A61M2207/00 ,  B32B3/02 ,  B32B15/08 ,  B32B15/20 ,  B32B27/08 ,  B32B27/32 ,  B32B27/325 ,  B32B27/36 ,  B32B2255/10 ,  B32B2255/205 ,  B32B2307/7242 ,  B32B2307/7246 ,  B32B2307/75 ,  B32B2439/46 ,  B32B2439/80 ,  Y10T428/13 ,  Y10T428/1303 ,  Y10T428/1352 ,  Y10T428/1359 ,  Y10T428/139

摘要： A medical container comprising a body for containing a medicament, the body of the medical container being formed of a multilayered film comprising (i) a layer formed of a linear polyolefin and (ii) a layer formed of a cyclic polyolefin adjacent to the layer (i), and the layer (i) formed of the linear polyolefin satisfying the following conditions (a) and/or (b): Condition (a): an amount of a liquid component, which remains after Soxhlet's extraction with organic solvents followed by evaporation of the solvents, is 0.2% by weight or less, and Condition (b): a branching degree of a component, which remains after Soxhlet's extraction with n-hexane followed by evaporation of n-hexane, is 50 or less per 1,000 carbon atoms.

摘要翻译： 一种医疗容器，包括用于容纳药物的主体，所述医疗容器的主体由多层膜形成，所述多层膜包括（i）由线性聚烯烃形成的层和（ii）由邻近所述层的环状聚烯烃形成的层 i）和由线性聚烯烃形成的满足以下条件（a）和/或（b）的层（i））：条件（a）：索格利特有机溶剂萃取后留下的液体组分的量 溶剂的蒸发为0.2重量％以下，条件（b）：在索氏提取后，用正己烷蒸发后残留的成分的分支度为每1000个碳原子数为50以下 原子

公开(公告)号：US08029878B2

公开(公告)日：2011-10-04

申请号：US11663886

申请日：2005-09-26

申请人： Kenji Omori ,  Takeshi Nizuka ,  Dai Sudo ,  Manabu Fujimoto ,  Masashi Moteki ,  Toyoaki Suzuki ,  Koichi Miura ,  Kaori Ikeda ,  Hideji Kashiwagi ,  Hidetoshi Myojyo

发明人： Kenji Omori ,  Takeshi Nizuka ,  Dai Sudo ,  Manabu Fujimoto ,  Masashi Moteki ,  Toyoaki Suzuki ,  Koichi Miura ,  Kaori Ikeda ,  Hideji Kashiwagi ,  Hidetoshi Myojyo

IPC分类号： B32B1/02 ,  B32B1/08

CPC分类号： A61J1/2093 ,  A61J1/10 ,  A61J1/2024 ,  A61M2207/00 ,  B32B3/02 ,  B32B15/08 ,  B32B15/20 ,  B32B27/08 ,  B32B27/32 ,  B32B27/325 ,  B32B27/36 ,  B32B2255/10 ,  B32B2255/205 ,  B32B2307/7242 ,  B32B2307/7246 ,  B32B2307/75 ,  B32B2439/46 ,  B32B2439/80 ,  Y10T428/13 ,  Y10T428/1303 ,  Y10T428/1352 ,  Y10T428/1359 ,  Y10T428/139

摘要： A medical container comprising a body for containing a medicament, the body of the medical container being formed of a multilayered film comprising (i) a layer formed of a linear polyolefin and (ii) a layer formed of a cyclic polyolefin adjacent to the layer (i), and the layer (i) formed of the linear polyolefin satisfying the following conditions (a) and/or (b): Condition (a): an amount of a liquid component, which remains after Soxhlet's extraction with organic solvents followed by evaporation of the solvents, is 0.2% by weight or less, and Condition (b): a branching degree of a component, which remains after Soxhlet's extraction with n-hexane followed by evaporation of n-hexane, is 50 or less per 1,000 carbon atoms.

摘要翻译： 一种医疗容器，包括用于容纳药物的主体，所述医疗容器的主体由多层膜形成，所述多层膜包括（i）由线性聚烯烃形成的层和（ii）由邻近所述层的环状聚烯烃形成的层 i）和由线性聚烯烃形成的满足以下条件（a）和/或（b）的层（i））：条件（a）：索格利特有机溶剂萃取后留下的液体组分的量 溶剂的蒸发为0.2重量％以下，条件（b）：在索氏提取后，用正己烷蒸发后残留的成分的分支度为每1000个碳原子数为50以下 原子

公开(公告)号：US5510425A

公开(公告)日：1996-04-23

申请号：US270182

申请日：1994-07-01

申请人： Hidekazu Matsuura ,  Yoshihide Iwasaki ,  Kaori Ikeda ,  Takayuki Suzuki ,  Masashi Tanaka ,  Yasuo Miyadera

发明人： Hidekazu Matsuura ,  Yoshihide Iwasaki ,  Kaori Ikeda ,  Takayuki Suzuki ,  Masashi Tanaka ,  Yasuo Miyadera

IPC分类号： C08G73/10 ,  C08L79/08 ,  C09J179/08 ,  H05K3/38 ,  C08F283/04 ,  C08L63/00

CPC分类号： C08L79/085 ,  C08G73/1042 ,  C08J5/24 ,  C08L79/08 ,  C09J179/08 ,  C08J2379/08 ,  H05K3/386 ,  Y10S525/928 ,  Y10T428/2852 ,  Y10T428/31511 ,  Y10T428/31721

摘要： A polymide comprises structural units represented by the following formula: ##STR1## wherein Ar is a group consisting of 10-90 mole % of a first specific structural sub-unit and 90-10 mole % of a second particular structural sub-unit. A process for the production of the polyimide and a thermosetting resin composition comprising the polyimide and a particular polymaleimide are also disclosed.

摘要翻译： 聚酰亚胺包括由下式表示的结构单元：其中Ar是由10-90摩尔％的第一特定结构子单元和90-10摩尔％的第二特定结构子单元组成的组。 还公开了制备聚酰亚胺的方法和包含聚酰亚胺和特定聚马来酰亚胺的热固性树脂组合物。